Make More Capital

Reporting on US Cannabis 🌱 Descheduling = common sense. News Aggregate - Not Advice

[Hirsh Jain @anandastrategy]

The Cannabis Boom is Moving South

[Abby Winnifred Rae @Lifeisshort8888]

Buried at the end of the MM article $msos

[The Dank Informer @TheDankInformer]

UNITED STATES DEPARTMENT OF JUSTICE

Drug Enforcement Administration

In the Matter of

Schedules of Controlled Substances:
Proposed Rescheduling of Marijuana

ORDER FOR TRANSCRIPT CORRECTIONS AND POST-HEARING BRIEFS

[Graham Farrar @grahamfarrar]

👀
US Federal Department of Justice:

“The intended beneficiaries of the CSA are the American public and scientists and medical practitioners seeking legitimate access to controlled substances for research and patient treatment,” the brief states. “Petitioners are not the intended beneficiaries of the CSA, nor do their interests systemically align with those beneficiaries. Petitioners invoke the interests of (1) drug screeners in avoiding loss of business and increased costs; (2) employers in avoiding the costs of revising drug-testing protocols; and (3) a pharmaceutical company in preventing market competition. Petitioners thus invoke pocketbook interests served by keeping all marijuana in schedule I.”

[Jord @InvestorJord]

So why not fully deschedule?

@realDonaldTrump @DEAHQ @TheJusticeDept @GOP @DAGToddBlanche $MSOS

[Hirsh Jain @anandastrategy]

Missouri marijuana sales reach record highs in May

@mogreenway
@mimcammj

"May 2026 was not only the highest total sales month, it was also the strongest month on a daily sales average basis, perhaps the strongest indicator of both market performance & overall trends."

https://t.co/6AOLygUb4C

[Trulieve_IR @Trulieve_IR]

Trulieve Announces Share Repurchase Program $TRUL $TCNNF https://t.co/0RE84fTUkI

[Trulieve_IR @Trulieve_IR]

Trulieve Announces Uplist to NYSE $TCNNF $TRUL Soon to be TRLV! https://t.co/8SApchtLWx

[JoeGriesler @JGriesler]

Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls June 29 hearings $MSOS https://t.co/FsDqqd4RSW

[Todd Harrison @todd_harrison]

Heard on the Street

I'm told TSX-listed names--and there are only two--will be able to list on the NYSE as an ADR with no minimum share price.

[Graham Farrar @grahamfarrar]

The studies keep coming...

Peer-reviewed, 107 million patients: states with legal cannabis saw up to 15% fewer opioid poisoning hospitalizations.

Cannabis is medicine.

https://t.co/fyCEZmypkI

[Anthony Martinelli @AMartinelliWA]

A bipartisan congressional bill that would allow state-legal marijuana businesses to list on major U.S. stock exchanges gained a new sponsor today, bringing the total to four. https://t.co/Clf44jvnB4

[CannaVestments @CannaVestments]

Solid q1 showing from @terrascendcorp: top-line and margin profile remained stable, alongside good cost controls. This provided for continued cash generation and a healthy balance sheet allowing for M&A opportunities ahead

[Anthony Martinelli @AMartinelliWA]

A proposal allowing veterans to receive medical marijuana recommendations from their Department of Veterans Affairs doctors was just given approval by the U.S. House Rules Committee. https://t.co/5yMrhc68Vm

[Anthony Martinelli @AMartinelliWA]

NEW: Legislation to significantly expand Georgia's medical cannabis program has been signed into law by Governor Brian Kemp (R). https://t.co/4bcaCiBcLL

[CannaVestments @CannaVestments]

A pretty good start to the year for @Trulieve. Results were marginally ahead of expectations on both rev/aEBITDA although down YoY despite 11 new stores opened in that time. Cash flow/margins were strong with good cost controls and immediate 280e relief for medical sales

[CannaVestments @CannaVestments]

Solid start to the year for @GTIGrows - strong YoY growth ahead of expectations, timely share buybacks, market share gains, and continued cash generation to support CapEx spend and potential M&A opportunities ahead

[CannaVestments @CannaVestments]

An okay start to the year for @Curaleaf_Inc. Good to see YoY growth resume at a decent clip and top-line/aEBITDA were both ahead of expectations. Despite the beat, Q1 aEBITDA margins of 19.6% were the lowest the company has posted since 2020 as price compression remains ongoing